LivaNova PLC (NASDAQ:LIVN) Receives Consensus Recommendation of "Buy" from Analysts

Shares of LivaNova PLC (NASDAQ:LIVN - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $69.17.

Several research analysts have recently commented on the company. The Goldman Sachs Group initiated coverage on LivaNova in a research note on Friday, October 4th. They issued a "buy" rating and a $65.00 price objective on the stock. Needham & Company LLC restated a "buy" rating and set a $75.00 target price on shares of LivaNova in a research note on Thursday, October 31st. Mizuho dropped their price target on shares of LivaNova from $80.00 to $70.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Stifel Nicolaus raised their price objective on shares of LivaNova from $70.00 to $72.00 and gave the company a "buy" rating in a research report on Thursday, July 25th. Finally, Baird R W upgraded shares of LivaNova from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, September 17th.

Institutional Investors Weigh In On LivaNova

Institutional investors have recently modified their holdings of the stock. Arizona State Retirement System increased its stake in LivaNova by 2.0% in the 2nd quarter. Arizona State Retirement System now owns 15,104 shares of the company's stock worth $828,000 after buying an additional 299 shares during the period. Atria Investments Inc raised its stake in shares of LivaNova by 6.2% during the third quarter. Atria Investments Inc now owns 5,653 shares of the company's stock valued at $297,000 after acquiring an additional 331 shares in the last quarter. Fifth Third Bancorp boosted its holdings in shares of LivaNova by 97.1% in the second quarter. Fifth Third Bancorp now owns 674 shares of the company's stock valued at $37,000 after purchasing an additional 332 shares during the period. Hexagon Capital Partners LLC grew its stake in LivaNova by 117.8% in the second quarter. Hexagon Capital Partners LLC now owns 684 shares of the company's stock worth $37,000 after purchasing an additional 370 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its holdings in shares of LivaNova by 7.3% in the third quarter. State of Alaska Department of Revenue now owns 6,246 shares of the company's stock valued at $328,000 after acquiring an additional 425 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

LivaNova Stock Performance

Shares of LivaNova stock traded down $0.35 on Friday, hitting $51.63. 341,476 shares of the company's stock were exchanged, compared to its average volume of 621,525. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The stock has a market capitalization of $2.80 billion, a PE ratio of 123.76 and a beta of 1.01. LivaNova has a 1 year low of $42.75 and a 1 year high of $64.47. The company has a 50-day simple moving average of $51.31 and a 200-day simple moving average of $53.08.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.